Welcome to our dedicated page for JanOne SEC filings (Ticker: JAN), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The SEC filings page for JanOne Inc. under the historical ticker JAN provides access to regulatory documents that trace the company’s corporate evolution into ALT5 Sigma Corporation and its development as a fintech and healthcare-focused issuer. These filings, which include Forms 8-K and other reports, document material events such as acquisitions, capital raises, governance changes, and the formal confirmation of the corporate name and ticker symbol change from JanOne Inc. (JAN) to ALT5 Sigma Corporation (ALTS).
Investors can review filings that describe the acquisition of blockchain financial technology provider ALT5 Sigma Inc. and its subsidiaries, the company’s inclusion in the Russell Microcap Index, and subsequent transactions involving registered direct offerings, private placements, and the establishment of a cryptocurrency treasury strategy involving WLFI tokens. Other filings outline the purchase of the Mswipe business, which offers multi-currency, fiat- and crypto-enabled payment card services, and detail the related consideration, warrants, and promissory notes.
These documents also provide insight into the company’s governance and oversight, including board and committee changes, compensation arrangements for executives, and the formation of special committees to review specific matters. For those studying the company’s biotech activities, periodic reports and current reports can be used to follow disclosures about its efforts to develop non-addicting pain treatments and address the opioid crisis.
On Stock Titan, SEC filings for JAN serve primarily as a historical record, since the company has adopted the name ALT5 Sigma Corporation and trades under the ticker ALTS. Users can use this page to locate past 8-Ks and related filings associated with the JAN symbol, then follow the sequence of disclosures into the ALT5 Sigma era. AI-powered tools on the platform can help summarize lengthy filings, highlight key terms of transactions, and make complex capital structure and governance information easier to interpret.
Alt5 Sigma Corporation filed an 8-K noting that incoming board observer Zak Folkman and incoming board chairman Zach Witkolf will appear on CNBC’s “Squawk Box” on August 12, 2025, beginning as early as 7:45 AM EST. During the segment, they may discuss the company’s treasury strategy, including a focus on acquiring WLFI tokens and incorporating USD1 into Alt5’s broader financial ecosystem. They may also describe how Alt5 aims to position itself at the forefront of institutional-grade cryptocurrency payment solutions, offering services that bridge crypto and everyday financial use, and their expectations for integrating USD1 to enhance its payment services suite.
ALT5 Sigma Corporation is offering 100,000,000 shares of common stock at $7.50 per share in a registered direct offering, generating gross proceeds of $750,000,000. The company agreed to pay placement agent fees equal to 3% (about $22,500,000) and to issue placement agent warrants equal to 3% of placement agent securities, exercisable at $8.25. Net proceeds are expected to be approximately $726,900,000. A concurrent private placement will issue 1,000,000 shares and pre-funded warrants to purchase up to 99,000,000 shares in exchange for $WLFI tokens; those tokens were contributed by the Lead Investor and were priced to the company at $0.20 per token.
The company intends to use $10,000,000 of net proceeds to settle litigation, pay debt and fund operations, and allocate the balance to acquire $WLFI tokens and establish a cryptocurrency treasury. After the offering, the company reports 121,609,376 shares outstanding. The prospectus highlights significant risks tied to the $WLFI strategy, including concentration, limited transferability and liquidity of $WLFI, regulatory and custody risks, potential Investment Company Act implications, and governance conflicts related to WLFI-affiliated parties.
ALT5 Sigma Corporation (Nasdaq: ALTS) filed a prospectus supplement describing an at-the-market program to sell up to $1.0 billion of common stock through A.G.P./Alliance Global Partners with commissions of 2.5% on the first $500 million and 2.0% thereafter. The supplement discloses a concurrent Registered Direct Offering of 100,000,000 shares at $7.50 per share (expected gross proceeds $750 million) and a Private Placement under which the Company received $750 million of $WLFI tokens from the Lead Investor and issued 1,000,000 shares plus pre-funded warrants exercisable for up to 99,000,000 shares.
The company had 21,609,376 shares outstanding prior to the offerings and reported a last Nasdaq sale price of $8.97 on August 8, 2025. The supplement highlights material dilution metrics (historical net tangible book value of $(23.1M) or $(1.07) per share; pro forma as adjusted to $8.21 per share after a hypothetical $1.0B offering) and extensive risk disclosures tied to the planned $WLFI treasury strategy, including token non-transferability, concentration risk, custody and cybersecurity risks, regulatory uncertainty, and possible implications under the Investment Company Act.
On August 11, 2025, ALT5 Sigma Corporation announced concurrent capital transactions that are expected to materially change its balance sheet and governance. The Company agreed to a registered direct offering to issue 100,000,000 shares at $7.50 per share (expected gross proceeds $750 million) and a concurrent private placement in which it received $750 million of $WLFI tokens from the Lead Investor in exchange for 1,000,000 shares at $7.50 and pre-funded warrants to purchase up to 99,000,000 additional shares.
The Company said it will use up to $10.0 million of net proceeds to settle litigation, pay debt and fund operations, with the remainder to purchase WLFI tokens and establish a cryptocurrency treasury. ALT5 also entered an ATM sales agreement to sell up to $1.0 billion of Common Stock, disclosed preliminary Q2 estimates (13-week revenue $6.0–6.5M; 26-week revenue $11.5–12.5M; cash ~ $9.5M; total assets ~$94–95M; current liabilities $58–59M) and announced board and management appointments, including Zachary Witkoff and Eric Trump.